Klus Pharma Inc.

This study is testing an experimental drug called SKB264, given alone or in combination with other therapies, for people with advanced or spreading non-small cell lung cancer. The main goals are to see if the treatment is safe and if it can shrink tumors. The trial will enroll ab…

This study is testing whether combining an experimental drug called SKB264 with an existing immunotherapy (pembrolizumab) can help control advanced cancers that have returned or spread. It will involve about 240 people with specific types of cervical, ovarian, prostate, bladder, …